{"entity":{"type":"insider","cik":"0001777760","url":"/insider/0001777760","json_url":"/insider/0001777760.json","name":"Miller Andrew Craig","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":53,"n_filings":23,"first":"2020-03-04","last":"2023-04-20","span_basis":"filed_date"},"name_variants":[{"name":"Miller Andrew Craig","source":"filing","n_filings":23,"first_seen":"2020-03-04","last_seen":"2023-04-20"}],"transactions":[{"id":8645922,"accession":"0000950170-23-013722","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-013722","line_url":"/filing/0000950170-23-013722#line-4","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":200.13,"price_display":"200.13","price_state":"stated","total_value":3001950.0,"total_display":"3,001,950.00","total_whole":"3,001,950","shares_owned_after":24400.0,"shares_owned_after_display":"24,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-20","filed_date":"2023-04-20","scope":"insider"},{"id":8645916,"accession":"0000950170-23-013722","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-013722","line_url":"/filing/0000950170-23-013722#line-2","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":200.16,"price_display":"200.16","price_state":"stated","total_value":6004800.0,"total_display":"6,004,800.00","total_whole":"6,004,800","shares_owned_after":30900.0,"shares_owned_after_display":"30,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-20","scope":"insider"},{"id":6256277,"accession":"0001593968-22-001691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-22-001691","line_url":"/filing/0001593968-22-001691#line-1","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":228.3,"price_display":"228.30","price_state":"stated","total_value":3424500.0,"total_display":"3,424,500.00","total_whole":"3,424,500","shares_owned_after":11250.0,"shares_owned_after_display":"11,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-02","scope":"insider"},{"id":6377168,"accession":"0001593968-22-001596","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-22-001596","line_url":"/filing/0001593968-22-001596#line-1","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":225.98,"price_display":"225.98","price_state":"stated","total_value":3389700.0,"total_display":"3,389,700.00","total_whole":"3,389,700","shares_owned_after":25500.0,"shares_owned_after_display":"25,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-10","filed_date":"2022-11-14","scope":"insider"},{"id":6687529,"accession":"0001593968-22-001570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-22-001570","line_url":"/filing/0001593968-22-001570#line-1","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":225.08,"price_display":"225.08","price_state":"stated","total_value":3376200.0,"total_display":"3,376,200.00","total_whole":"3,376,200","shares_owned_after":38500.0,"shares_owned_after_display":"38,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":5122929,"accession":"0001593968-21-002357","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001593968-21-002357","line_url":"/filing/0001593968-21-002357","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2827.0,"shares_display":"2,827","price_per_share":142.0309090909091,"price_display":"142.03","price_state":"stated","total_value":401521.38,"total_display":"401,521.38","total_whole":"401,521","shares_owned_after":52540.0,"shares_owned_after_display":"52,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider","n_lines":6},{"id":4832878,"accession":"0001593968-21-002238","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001593968-21-002238","line_url":"/filing/0001593968-21-002238#line-7","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3029.0,"shares_display":"3,029","price_per_share":125.17,"price_display":"125.17","price_state":"stated","total_value":379139.93,"total_display":"379,139.93","total_whole":"379,140","shares_owned_after":27827.0,"shares_owned_after_display":"27,827","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-04","filed_date":"2021-10-05","scope":"insider"},{"id":4832874,"accession":"0001593968-21-002238","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001593968-21-002238","line_url":"/filing/0001593968-21-002238","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13471.0,"shares_display":"13,471","price_per_share":124.17482072600401,"price_display":"124.17","price_state":"stated","total_value":1672759.01,"total_display":"1,672,759.01","total_whole":"1,672,759","shares_owned_after":30856.0,"shares_owned_after_display":"30,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider","n_lines":6},{"id":5265728,"accession":"0001593968-21-002085","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-21-002085","line_url":"/filing/0001593968-21-002085#line-4","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2673.0,"shares_display":"2,673","price_per_share":125.51,"price_display":"125.51","price_state":"stated","total_value":335488.23,"total_display":"335,488.23","total_whole":"335,488","shares_owned_after":44327.0,"shares_owned_after_display":"44,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider"},{"id":5265725,"accession":"0001593968-21-002085","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001593968-21-002085","line_url":"/filing/0001593968-21-002085","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":118.485,"price_display":"118.48","price_state":"stated","total_value":651667.5,"total_display":"651,667.50","total_whole":"651,668","shares_owned_after":47500.0,"shares_owned_after_display":"47,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-03","scope":"insider","n_lines":3},{"id":4576763,"accession":"0001593968-21-001993","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-21-001993","line_url":"/filing/0001593968-21-001993","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":103.92250727272727,"price_display":"103.92","price_state":"stated","total_value":571573.79,"total_display":"571,573.79","total_whole":"571,574","shares_owned_after":52600.0,"shares_owned_after_display":"52,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider","n_lines":3},{"id":5077696,"accession":"0001593968-21-001617","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001593968-21-001617","line_url":"/filing/0001593968-21-001617#line-6","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8334.0,"shares_display":"8,334","price_per_share":131.44,"price_display":"131.44","price_state":"stated","total_value":1095420.96,"total_display":"1,095,420.96","total_whole":"1,095,421","shares_owned_after":45500.0,"shares_owned_after_display":"45,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-14","scope":"insider"},{"id":5077681,"accession":"0001593968-21-001617","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-21-001617","line_url":"/filing/0001593968-21-001617#line-4","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8333.0,"shares_display":"8,333","price_per_share":129.33,"price_display":"129.33","price_state":"stated","total_value":1077706.89,"total_display":"1,077,706.89","total_whole":"1,077,707","shares_owned_after":45500.0,"shares_owned_after_display":"45,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-14","scope":"insider"},{"id":5077663,"accession":"0001593968-21-001617","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001617","line_url":"/filing/0001593968-21-001617#line-2","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13333.0,"shares_display":"13,333","price_per_share":123.68,"price_display":"123.68","price_state":"stated","total_value":1649025.44,"total_display":"1,649,025.44","total_whole":"1,649,025","shares_owned_after":45500.0,"shares_owned_after_display":"45,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-14","scope":"insider"},{"id":5382004,"accession":"0001593968-21-001293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001293","line_url":"/filing/0001593968-21-001293#line-2","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":110.43,"price_display":"110.43","price_state":"stated","total_value":552150.0,"total_display":"552,150.00","total_whole":"552,150","shares_owned_after":45500.0,"shares_owned_after_display":"45,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-10","filed_date":"2021-05-12","scope":"insider"},{"id":4430424,"accession":"0001593968-21-001113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001113","line_url":"/filing/0001593968-21-001113#line-2","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":114.22,"price_display":"114.22","price_state":"stated","total_value":571100.0,"total_display":"571,100.00","total_whole":"571,100","shares_owned_after":45500.0,"shares_owned_after_display":"45,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-12","filed_date":"2021-04-14","scope":"insider"},{"id":4332847,"accession":"0001593968-21-000905","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-000905","line_url":"/filing/0001593968-21-000905#line-2","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":118.48,"price_display":"118.48","price_state":"stated","total_value":592400.0,"total_display":"592,400.00","total_whole":"592,400","shares_owned_after":45500.0,"shares_owned_after_display":"45,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-12","scope":"insider"},{"id":5228871,"accession":"0001593968-21-000439","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-000439","line_url":"/filing/0001593968-21-000439#line-2","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":114.06,"price_display":"114.06","price_state":"stated","total_value":570300.0,"total_display":"570,300.00","total_whole":"570,300","shares_owned_after":45500.0,"shares_owned_after_display":"45,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-12","scope":"insider"},{"id":4737871,"accession":"0001593968-21-000123","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-21-000123","line_url":"/filing/0001593968-21-000123","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":105.11,"price_display":"105.11","price_state":"stated","total_value":525550.0,"total_display":"525,550.00","total_whole":"525,550","shares_owned_after":45500.0,"shares_owned_after_display":"45,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-12","scope":"insider","n_lines":2},{"id":2349588,"accession":"0001593968-20-002355","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-20-002355","line_url":"/filing/0001593968-20-002355","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":94.82,"price_display":"94.82","price_state":"stated","total_value":474100.0,"total_display":"474,100.00","total_whole":"474,100","shares_owned_after":45500.0,"shares_owned_after_display":"45,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-10","filed_date":"2020-12-14","scope":"insider","n_lines":2},{"id":2873690,"accession":"0001593968-20-002189","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001593968-20-002189","line_url":"/filing/0001593968-20-002189#line-8","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8334.0,"shares_display":"8,334","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":833400.0,"total_display":"833,400.00","total_whole":"833,400","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-12","scope":"insider"},{"id":2873684,"accession":"0001593968-20-002189","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001593968-20-002189","line_url":"/filing/0001593968-20-002189#line-6","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8333.0,"shares_display":"8,333","price_per_share":100.01,"price_display":"100.01","price_state":"stated","total_value":833383.33,"total_display":"833,383.33","total_whole":"833,383","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"},{"id":2873678,"accession":"0001593968-20-002189","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-20-002189","line_url":"/filing/0001593968-20-002189","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13333.0,"shares_display":"13,333","price_per_share":103.8,"price_display":"103.80","price_state":"stated","total_value":1383965.4,"total_display":"1,383,965.40","total_whole":"1,383,965","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider","n_lines":2},{"id":2081071,"accession":"0001593968-20-002023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-002023","line_url":"/filing/0001593968-20-002023#line-2","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":78.67,"price_display":"78.67","price_state":"stated","total_value":393350.0,"total_display":"393,350.00","total_whole":"393,350","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-12","filed_date":"2020-10-13","scope":"insider"},{"id":3151486,"accession":"0001593968-20-001859","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-001859","line_url":"/filing/0001593968-20-001859#line-2","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":75.52,"price_display":"75.52","price_state":"stated","total_value":377600.0,"total_display":"377,600.00","total_whole":"377,600","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-10","filed_date":"2020-09-10","scope":"insider"},{"id":2493402,"accession":"0001593968-20-001477","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001593968-20-001477","line_url":"/filing/0001593968-20-001477#line-11","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8334.0,"shares_display":"8,334","price_per_share":97.58,"price_display":"97.58","price_state":"stated","total_value":813231.72,"total_display":"813,231.72","total_whole":"813,232","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-16","scope":"insider"},{"id":2493398,"accession":"0001593968-20-001477","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001593968-20-001477","line_url":"/filing/0001593968-20-001477","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8333.0,"shares_display":"8,333","price_per_share":92.38,"price_display":"92.38","price_state":"stated","total_value":769802.54,"total_display":"769,802.54","total_whole":"769,803","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-16","scope":"insider","n_lines":2},{"id":2493381,"accession":"0001593968-20-001477","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-20-001477","line_url":"/filing/0001593968-20-001477","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8333.0,"shares_display":"8,333","price_per_share":93.28,"price_display":"93.28","price_state":"stated","total_value":777302.24,"total_display":"777,302.24","total_whole":"777,302","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-12","filed_date":"2020-06-16","scope":"insider","n_lines":2},{"id":2187789,"accession":"0001593968-20-001316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-001316","line_url":"/filing/0001593968-20-001316#line-2","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":90.64,"price_display":"90.64","price_state":"stated","total_value":2266000.0,"total_display":"2,266,000.00","total_whole":"2,266,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-02","scope":"insider"},{"id":3265568,"accession":"0001593968-20-001099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-001099","line_url":"/filing/0001593968-20-001099#line-2","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":76.98,"price_display":"76.98","price_state":"stated","total_value":1924500.0,"total_display":"1,924,500.00","total_whole":"1,924,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-01","filed_date":"2020-05-04","scope":"insider"},{"id":2157434,"accession":"0001593968-20-000988","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-20-000988","line_url":"/filing/0001593968-20-000988#line-4","is_derivative":false,"issuer_cik":"0001771917","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001771917","owner_cik":"0001777760","owner_name":"Miller Andrew Craig","owner_display_name":"Miller Andrew Craig","owner_url":"/insider/0001777760","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14346.0,"shares_display":"14,346","price_per_share":64.37,"price_display":"64.37","price_state":"stated","total_value":923452.02,"total_display":"923,452.02","total_whole":"923,452","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-01","filed_date":"2020-04-03","scope":"insider"}],"collapsed":true,"next_cursor":"2020-04-01|2157434","ledger_fault":false,"count":{"value":53,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":53,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":53},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001771917","name":"Karuna Therapeutics, Inc.","url":"/issuer/0001771917","role":"Officer (Chief Operating Officer)","n_filings":23,"first_seen":"2020-03-04","last_seen":"2023-04-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001777760","retrieved_at":"2026-08-23T03:14:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}